©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
The Spin Trap -(4-Pyridyl-1-oxide)-N-tert-butylnitrone Stimulates Peroxidase-mediated Oxidation of Deferoxamine
IMPLICATIONS FOR PHARMACOLOGICAL USE OF SPIN-TRAPPING AGENTS (*)

(Received for publication, August 1, 1995; and in revised form, September 28, 1995)

Michael L. McCormick (1) Garry R. Buettner (2) Bradley E. Britigan (1) (3)(§)

From the  (1)Research Service, Veterans Administration Medical Center, Iowa City, Iowa 52246 and the (2)Electron Spin Resonance Facility and the (3)Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa 52242

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The iron chelator deferoxamine (Desferal; DSFL) reacts with peroxidases and H(2)O(2) to form the DSFL radical (DSFL), which can be detected by EPR spectroscopy. We have found that DSFL formation resulting from exposure to H(2)O(2) and any of a number of different peroxidases is greatly enhanced in the presence of the nitrone spin trap alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone (4-POBN). This enhancement was seen at 4-POBN concentrations as low as 200 µM. We observed a modest enhancement of DSFL formation with 2-methyl-2-nitrosopropane. However, no enhancement was seen with 5,5-dimethyl-1-pyrroline 1-oxide (DMPO) or phenyl-tert-butylnitrone. A modest enhancement was also seen with the nitrone compound pyridine N-oxide. 2-Methyl-2-nitrosopropane and pyridine N-oxide were additionally capable of increasing enzymatic peroxidase activity as measured by o-dianisidine and/or tetramethylbenzidine oxidation. Furthermore, at high concentrations of 4-POBN (50 mM) in the absence of DSFL, we detected a peroxidase/H(2)O(2)-dependent 12-line EPR spectrum that likely represents a 4-POBN/4-POBN nitrogen-centered spin adduct. In the presence of both 4-POBN (10 mM) and DMPO (100 mM), an 18-line EPR spectrum was observed consistent with formation of a DMPO/4-POBN nitrogen-centered spin adduct. Thus, the nitrone spin trap 4-POBN can enhance the peroxidase-mediated formation of DSFL, possibly via the formation of a transient 4-POBN radical species. These data suggest the importance of assessing the potential for nitrone spin traps to both inhibit and enhance biological oxidation prior to their use as potential pharmacological agents.


INTRODUCTION

Deferoxamine (Desferal; DSFL) (^1)is a potent iron chelator used clinically to treat iron overload(1) . By binding iron in such a way that it greatly hinders redox cycling, DSFL can reduce the potential for damage to normal tissue from iron-catalyzed HO formation(2) . Reaction of various peroxidases (e.g. HRP, LPO, MPO, and eosinophil peroxidase) with H(2)O(2) in the presence of DSFL leads to the formation of the DSFL radical (DSFL), a nitroxide radical that can be detected by EPR spectroscopy(3) . DSFL is capable of damaging vitamins and enzymes(4) , and its formation is thought to be dependent on formation of Compound II of the peroxidase(5) , although the exact reaction process remains ill defined.

We recently demonstrated that human neutrophils, monocytes, and eosinophils generate HO via a peroxidase-dependent mechanism involving MPO or eosinophil peroxidase(6, 7) . In the course of work examining the ability of DSFL to modulate this HO formation in its role as an iron chelator, we observed that MPO-dependent formation of DSFL increased dramatically in the presence of the nitrone spin trap 4-POBN. Due to their oxidant-scavenging properties, nitrone spin traps have been studied as potential therapeutic modalities for a variety of pathological processes believed to be mediated by reactive oxidant species(8, 9, 10, 11) . Our observations with 4-POBN and DSFL raised the possibility that some nitrone spin traps could enhance rather than inhibit peroxidase-mediated oxidant injury under some circumstances. Accordingly, we examined 1) whether 4-POBN enhances the ability of other peroxidases to generate DSFL, 2) the extent to which spin traps other than 4-POBN enhance peroxidase-mediated DSFL formation, and 3) the mechanism(s) involved.


EXPERIMENTAL PROCEDURES

Materials

HRP and bovine LPO were obtained from Sigma. Human MPO was provided by Dr. William Nauseef (University of Iowa, Iowa City, IA). Human eosinophils were isolated as described previously (7, 12) and lysed by repeated freeze-thaw cycles in order to obtain crude lysates with eosinophil peroxidase activity. DSFL, L-tryptophan, 3-hydroxybenzaldehyde, 4-POBN, 5,5-dimethyl-1-pyrroline 1-oxide (DMPO), 2-methyl-2-nitrosopropane (MNP) dimer, and phenyl-tert-butylnitrone (PBN) were also obtained from Sigma. Salicylic acid was obtained from Fisher. Pyridine N-oxide (PNO), 4-methyl-PNO, pyridine, and diethylenetriaminepentaacetic acid (DTPA) were obtained from Aldrich.

EPR Spectroscopy

For the generation of DSFL, 100 µM H(2)O(2) was added to a solution containing 1-100 µM DSFL and one of the following: HRP (2-20 µg/ml), LPO (2-20 µg/ml), MPO (40-400 units/ml), or lysed eosinophils. After 10 min, samples were transferred to an EPR flat cell, and the resulting EPR spectra were obtained at room temperature using a Bruker Model ESP 300 spectrometer. Unless otherwise stated, instrument settings were as follows: microwave power, 20 milliwatts; modulation frequency, 100 kHz; modulation amplitude, 0.9 G; sweep rate, 0.4 G/min; and response time, 0.6 s.

All EPR experiments were performed in 20 mM phosphate buffer, pH 7.4, pretreated with Chelex 100 analytical grade chelating resin (Bio-Rad) to remove adventitious iron(13) . In addition, to hinder any remaining redox-active metals, 100 µM DTPA was added to all samples during EPR experiments.

Peroxidase Assays

Peroxidase activity was determined by two methods, each of which is based on its ability to oxidize a specific substrate.

Tetramethylbenzidine

Peroxidase activity was initially determined by the method of Bozeman et al.(14) . HRP (5-20 ng/ml) or LPO (0.4-2 µg/ml) was diluted in 50 mM acetate buffer, pH 5.4, in the presence of the various compounds. Tetramethylbenzidine (Sigma) and H(2)O(2) were added to yield final concentrations of 1.4 and 0.3 mM, respectively (final volume of 0.7 ml). After 3 min, the reaction was terminated by addition of 0.02 ml of bovine liver catalase (0.3 mg/ml stock solution; Sigma) and 0.68 ml of cold acetic acid (0.2 M stock solution). The absorbance of the resulting solution was then determined at 635 nm. Effects of spin traps on peroxidase activity are expressed as -fold increase over control (peroxidase only) values.

o-Dianisidine

Peroxidase activity was also determined as the ability to oxidize o-dianisidine as described previously (15) . In this assay, HRP (5-20 ng/ml) or LPO (0.4-2 µg/ml) was added to a 10 mM sodium phosphate buffer solution, pH 6.0, containing 0.88 mM H(2)O(2), 260 µMo-dianisidine (Sigma), and the various compounds. Change in absorbance at 460 nm was determined for the first 30 s of the reaction. Effects of spin traps on peroxidase activity are expressed as -fold increase over control (peroxidase only) values.


RESULTS AND DISCUSSION

Formation of the DSFL Radical by the Peroxidase/H(2)O(2) System

DSFL, an iron chelator used clinically in cases of iron overload, is susceptible to enzymatic oxidation by various peroxidases(3, 5) . Consistent with the results of others(3) , addition of DSFL to a HRP/H(2)O(2) system yielded the characteristic DSFL as detected by EPR (Fig. 1). The steady-state concentration of DSFL increased as the level of DSFL added to the system increased, but it was not linear over the 100-fold range of DSFL concentrations used. Under identical experimental conditions, we observed DSFL formation by MPO, LPO, and lysed eosinophils (i.e. eosinophil peroxidase) in the presence of H(2)O(2) (data not shown). In each case, both H(2)O(2) and peroxidase were required for the formation of DSFL (data not shown). Formation of this radical by the HRP/H(2)O(2) system was clearly observed at DSFL concentrations as low as 10 µM. When administered to humans, stable plasma concentrations of DSFL as high as 20 µM have been reported(16) . Thus, at in vivo sites of inflammation in such treated individuals, neutrophil-derived MPO and eosinophil-derived eosinophil peroxidase could lead to the formation of DSFL.


Figure 1: DSFL formation by a peroxidase/H(2)O(2) system. A, EPR spectrum seen following addition of 1 µM DSFL to a system containing 100 µM H(2)O(2) and 2 mg/ml HRP; B, same as A, but in the presence of 10 µM DSFL; C, same as A, but in the presence of 100 µM DSFL. Results are representative of three separate experiments. Note that for the first spectrum shown, the instrument gain was increased 4-fold. EPR parameters for DSFL are a^N = 7.84 G and a^H (2) = 6.23 G.



DSFL seen in the above experiments is likely a direct product of the action of the peroxidase/H(2)O(2) system on DSFL(3) . It has been reported that DSFL can be formed directly by a scavenging reaction between DSFL and HO(3) . This suggested that the DSFL we observed could be a result of DSFL reacting with HO generated by the peroxidase/H(2)O(2) system, forming DSFL as a consequence. However, using the highly sensitive 4-POBN/ethanol spin-trapping system(6, 17, 18) , we were unable to detect significant production of HO by the combination of H(2)O(2) and HRP, LPO, or MPO (data not shown). These data suggest that peroxidase enzymes form DSFL predominantly via their oxidizing intermediates, i.e. Compounds I and/or II, and not via formation of a HO intermediate.

Enhanced DSFL Radical Formation in the Presence of 4-POBN

In the course of the above experiments, we surprisingly observed a 2-5-fold enhancement of DSFL formation in the presence of the nitrone spin trap 4-POBN at the concentration (10 mM) typically employed in our spin-trapping studies (Fig. 2). Results were qualitatively similar regardless of the peroxidase employed, implying a common mechanism of action in the enhancement of DSFL formation. However, the magnitude of increase varied with the peroxidase employed. In the presence of 20 µg/ml HRP, this enhancement was typically 4-fold, whereas with 20 µg/ml LPO, this enhancement was as high as 20-fold. Enhanced DSFL formation could be observed at 4-POBN concentrations as low as 200 µM and increased linearly over the range of 200 µM to 10 mM 4-POBN. Furthermore, by reducing the levels of peroxidase 10-fold, the effects of 4-POBN became more dramatic. Thus, in the presence of 2 µg/ml LPO and 200 µM 4-POBN, DSFL was easily detected (Fig. 3B), whereas in the absence of 4-POBN (Fig. 3A), it was not seen.


Figure 2: Enhanced DSFL formation in the presence of the nitrone spin trap 4-POBN. A, EPR spectrum obtained with a horseradish peroxidase/H(2)O(2) system (20 µg/ml HRP, 100 µM H(2)O(2)) containing 10 mM 4-POBN; B, same as A, but containing 10 µM DSFL (no 4-POBN); C, same as A, but containing both 10 mM 4-POBN and 10 µM DSFL. Results are representative of three separate experiments. Note that for the first spectrum shown, the instrument gain was increased 4-fold.




Figure 3: DSFL formation in the presence of various spin traps. A, EPR spectrum obtained with a lactoperoxidase/H(2)O(2) system (2 µg/ml LPO, 100 µM H(2)O(2)) containing 10 µM DSFL; B, same as A, but in the presence of 200 µM 4-POBN; C, same as A, but in the presence of 100 mM DMPO; D, same as A, but in the presence of 10 mM PBN; E, same as A, but in the presence of 10 mM MNP; F, same as A, but in the presence of 10 mM PNO. Results are representative of three separate experiments. Note the concentration of peroxidase used is 10-fold less than in Fig. 1and Fig. 2.



Effect of Other Compounds on DSFL Radical Formation

In an effort to better understand the mechanism(s) responsible for the enhancement of DSFL formation, we tested the ability of various compounds representative of the structural moieties of 4-POBN to enhance the formation of DSFL by the various peroxidase/H(2)O(2) systems. Initially, we examined the two main structural components of 4-POBN. The nitroso spin trap MNP is contained in the structure of 4-POBN, but has no aromatic ring structure (Fig. 4). In contrast, the compound PNO, while not a spin trap, has a pyridine ring structure that is identical to that found in 4-POBN (Fig. 4), i.e. it includes a nitrogen oxide group, but lacks the MNP-like side chain. Surprisingly, at a concentration of 10 mM, both MNP and PNO demonstrated a significant enhancement of DSFL formation, but to a lesser extent than 4-POBN (Fig. 3, compare A with E and A with F). Qualitatively similar increases in DSFL formation in the presence of 4-POBN and MNP, but not PNO, have been observed with MPO and isolated eosinophils (data not shown). This raised the possibility that the nitrone moiety and the aromatic ring structure are at least partially responsible for the enhancement of DSFL formation.


Figure 4: Chemical structures of 4-POBN, PBN, MNP, PNO, 4-methyl-PNO, DMPO, and pyridine.



One of the possible explanations for the partial activity of PNO was its lack of a side chain at the 4-position of the aromatic ring. We thus tested 4-picoline N-oxide (4-methyl-PNO) (Fig. 4) in the peroxidase/H(2)O(2) system. Surprisingly, no enhancement of DSFL formation was seen in the presence of this compound (data not shown). Another related compound of interest was pyridine, representing the aromatic ring of PNO without the oxide group (Fig. 4). Addition of 10 mM pyridine to the peroxidase/H(2)O(2) system also demonstrated no increase in DSFL formation (data not shown). Thus, two compounds, MNP and PNO, which share structural features with 4-POBN, were able to enhance DSFL formation, implying a role for the nitrone moiety as well as the nitrogen oxide moiety in the aromatic ring.

We were also interested to see if this enhancement was seen with other nitrone spin traps. The spin trap PBN is structurally similar to 4-POBN, differing only at the 4-position of the aromatic ring (Fig. 4). This feature makes PBN far more lipophilic than 4-POBN. At a concentration of 10 mM, the highest concentration we were able to effectively utilize due to solubility constraints, PBN demonstrated no enhancement of DSFL formation (Fig. 3, A and D). This implies that the spin-trapping nitrone moiety is not involved, but rather it is the nitrogen oxide group in the aromatic ring (Fig. 4) that is important for the enhanced radical formation in the presence of 4-POBN.

Another commonly used nitrone spin trap is DMPO. Aside from the shared nitrone group, DMPO is structurally dissimilar to 4-POBN (Fig. 4). Addition of up to 100 mM DMPO to the peroxidase/H(2)O(2) systems did not lead to enhancement of peroxidase-mediated DSFL formation under our experimental conditions (Fig. 3, A and C). The lack of effect with DMPO suggests that the enhancement of peroxidase-mediated DSFL formation is not a general property of nitrone spin traps, but that features unique to the 4-POBN molecule are responsible for the effect.

Effect of Spin Traps and Related Compounds on Peroxidase Activity

We next wanted to determine whether the enhancement of DSFL formation was the result of a direct interaction between the nitrone compound and DSFL or simply the result of a generalized increase in peroxidase activity. We chose to measure enzymatic peroxidase activity using two distinct assay systems, the oxidation of tetramethylbenzidine and the oxidation of o-dianisidine.

Addition of 4-POBN to either the HRP or LPO system failed to demonstrate any significant increase in peroxidase activity (Table 1). DMPO, PBN, and 4-methyl-PNO, all of which failed to demonstrate an increase in DSFL formation, also failed to demonstrate increased peroxidase activity (Table 1). MNP and PNO, however, did demonstrate an enhancement of peroxidase activity (Table 1). The increases in enzymatic peroxidase activity seen with MNP and PNO were of the same magnitude as those seen in the spin-trapping experiments ( Table 1and Fig. 3). Pyridine also demonstrated a large increase in enzymatic HRP activity, which was not seen with LPO (Table 1). The large increase in enzymatic HRP activity observed in the presence of pyridine was surprising given the lack of enhancement of DSFL formation seen with this compound in the spin-trapping studies.



We can thus conclude that the enhanced DSFL formation seen with the peroxidase/H(2)O(2) system in the presence of 4-POBN is not attributable to its ability to increase peroxidase activity. It is possible that the ability of both MNP and PNO to enhance DSFL formation is explainable on the basis of an increase in enzymatic activity, but this is in contrast to the pyridine data showing an increase in enzymatic activity with no concomitant increase in DSFL formation. These data suggest that it may be the ring structure, which 4-POBN and PNO share, that is of critical importance to the ability of 4-POBN to enhance peroxidase-dependent DSFL formation.

Soriani et al.(5) have proposed that peroxidase-mediated DSFL formation requires the formation of Compound II of the peroxidase. Inclusion of the Compound II-promoting agents L-tryptophan, 3-hydroxybenzaldehyde, or salicylate (all at 10 mM) in the DSFL/H(2)O(2)/peroxidase system yielded no observable increase in DSFL formation under our experimental conditions (data not shown). Thus, the enhancement of DSFL formation seen with 4-POBN is likely not due to an increase in peroxidase Compound II formation.

Spin Trapping a Radical from 4-POBN in the Peroxidase/H(2)O(2) System

Rather than directly increasing the enzymatic activity of the peroxidase, it is possible that 4-POBN is an oxidizable substrate for the peroxidase, forming a radical species that in turn abstracts an electron (hydrogen atom) from DSFL to form DSFL. This would have the net effect of increasing the steady-state level of DSFL. If this transient 4-POBN species were a free radical (4-POBN), we hypothesized that it might be possible to detect its presence directly using EPR. However, previous experiments described above showed that the reaction of either HRP or LPO with H(2)O(2) (without DSFL) in the presence of 10 mM 4-POBN yields no detectable spin-active species. Since this could be related to a very short half-life of such a 4-POBN radical, we explored the possibility that spin trapping could be used to detect such a species.

When 10 mM 4-POBN was added to either the HRP/H(2)O(2) or LPO/H(2)O(2) system in the presence of 100 mM DMPO, the EPR spectrum shown in Fig. 5A was generated. No spectrum above background was observed in the absence of 4-POBN. We propose that this spectrum represents a DMPO/4-POBN spin adduct (a = 15.9 G, a = 13.85 G, and a = 4.64 G). A computer-simulated spectrum with these parameters is shown in Fig. 5B.


Figure 5: EPR spectra representing the DMPO/4-POBN spin adduct. A, EPR spectrum seen following addition of 10 mM 4-POBN and 100 mM DMPO to a system containing 100 µM H(2)O(2) and 20 µg/ml HRP; B, computer simulation of a DMPO/4-POBN spin adduct, where a^H = 15.9 G, a(1)^N = 13.85 G, and a(2)^N = 4.635 G. Results are representative of three separate experiments.



Further evidence for the formation of a 4-POBN radical during the reaction of the peroxidases, H(2)O(2), and 4-POBN was obtained by increasing the concentration of 4-POBN to 50 mM. Under such conditions, we were able to routinely observe a 12-line EPR spectrum consistent with the formation of a 4-POBN/4-POBN spin adduct, where a^H = 1.8 G, a(1)^N = 14.9 G, and a(2)^N = 1.85 G (Fig. 6A). A computer-simulated spectrum with these parameters is shown in Fig. 6B.


Figure 6: EPR spectra representing the 4-POBN/4-POBN spin adduct. A, EPR spectrum seen following addition of 50 mM 4-POBN to a system containing 100 µM H(2)O(2) and 20 µg/ml HRP; B, computer simulation of a 4-POBN/4-POBN spin adduct, where a^H = 1.8 G, a(1)^N = 14.9 G, and a(2)^N = 1.85 G. Results are representative of three separate experiments.



The detection of the above spin adducts strengthens the possibility that the enhancement of DSFL formation by 4-POBN is due to the generation of an oxidizing 4-POBN radical species. This radical in turn enhances the effectiveness of peroxidase-mediated oxidation of DSFL. We assume that the 4-POBN radical species being trapped is derived from the pyridyl-associated nitrone moiety, but cannot rule out completely an association with the tert-butyl-associated nitrone moiety.

In summary, we have shown that under certain conditions, the nitrone spin trap 4-POBN, the nitroso compound MNP, and the nitrogen oxide compound PNO can enhance DSFL radical formation by several peroxidases. It is likely, however, that these compounds work in different ways to achieve the same end. The biological implications of these observations remain unclear. Nevertheless, nitrones and other related compounds have been investigated as pharmacological agents for the treatment of various pathological states(8, 9, 10, 11) .

Our data suggest the need for caution in the use of such agents in conditions in which peroxidase-derived oxidants may be involved. Peroxidase-mediated oxidation of compounds other than DSFL could potentially be enhanced in the presence of compounds such as 4-POBN. 4-POBN has been observed to have toxic effects. Normally perfused rat hearts demonstrated a 40% loss of cardiac function following a 15-min exposure to 4-POBN. (^2)In addition, rat hearts reperfused following 30 min of ischemia, which typically recover 40-55% of their preischemic function, demonstrated no recovery if they received prior exposure to 4-POBN.^2 These observations may relate to 4-POBN's susceptibility to oxidation by peroxidase-like processes. In light of evidence demonstrating a role for peroxidase-mediated oxidation products in human pathology and given the increasing use of nitrone spin traps as pharmacological agents, it is important to evaluate the potential for these nitrone spin traps to both abrogate and enhance free radical-mediated oxidation.


FOOTNOTES

*
This work was supported in part by awards from the Veterans Administration Research Service and by National Institutes of Health Grants HL-44275, AI-28412, and AI-34954. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Performed this work in part during tenure as an Established Investigator of the American Heart Association. To whom correspondence should be addressed: Dept. of Medicine, University of Iowa, 200 Hawkins Dr., SW54 GH, Iowa City, IA 52242. Tel.: 319-356-3674; Fax: 319-356-4600.

(^1)
The abbreviations used are: DSFL, deferoxamine (Desferal); DSFL, deferoxamine radical; HRP, horseradish peroxidase; LPO, lactoperoxidase (bovine); MPO, myeloperoxidase (human); 4-POBN, alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone; DMPO, 5,5-dimethyl-1-pyrroline 1-oxide; MNP, 2-methyl-2-nitrosopropane; PBN, phenyl-tert-butylnitrone; PNO, pyridine N-oxide; DTPA, diethylenetriaminepentaacetic acid.

(^2)
J. H. Kramer and W. B. Weglicki, personal communication.


ACKNOWLEDGEMENTS

We thank Dr. William Nauseef for kindly providing human MPO.


REFERENCES

  1. Modell, B., Letsky, E. A., Flynn, D. M., Peto, R., and Weatherall, D. J. (1982) Br. Med. J. 284, 1081-1084 [Medline] [Order article via Infotrieve]
  2. Gutteridge, J. M. C., Richmond, R., and Halliwell, B. (1979) Biochem. J. 184, 469-472 [Medline] [Order article via Infotrieve]
  3. Morehouse, K. M., Flitter, W. D., and Mason, R. P. (1987) FEBS Lett. 222, 246-250 [CrossRef][Medline] [Order article via Infotrieve]
  4. Davies, M. J., Donkor, R., Dunster, C. A., Gee, C. A., Jonas, S., and Willson, R. L. (1987) Biochem. J. 246, 725-729 [Medline] [Order article via Infotrieve]
  5. Soriani, M., Mazzuca, S., Quaresima, V., and Minetti, M. (1993) Free Radical Biol. & Med. 14, 589-599 [CrossRef]
  6. Ramos, C. L., Pou, S., Britigan, B. E., Cohen, M. S., and Rosen, G. M. (1992) J. Biol. Chem. 267, 8307-8312 [Abstract/Free Full Text]
  7. McCormick, M. L., Roeder, T. L., Railsback, M. A., and Britigan, B. E. (1994) J. Biol. Chem. 269, 27914-27919 [Abstract/Free Full Text]
  8. Hearse, D. J., and Tosaki, A. (1987) Circ. Res. 60, 373-383
  9. Bradamante, S., Monti, E., Paracchini, L., Lazzarini, E., and Piccinini, F. (1992) J. Mol. Cell. Cardiol. 24, 375-386 [CrossRef][Medline] [Order article via Infotrieve]
  10. Pedraza-Chaverri, J., Tapia, E., and Bobadilla, N. (1992) Renal Failure 14, 467-471 [Medline] [Order article via Infotrieve]
  11. Oliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., and Floyd, R. A. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 5144-5147 [Abstract]
  12. Roberts, R. L., and Gallin, J. I. (1985) Blood 65, 433-440 [Abstract]
  13. Buettner, G. R. (1988) J. Biochem. Biophys. Methods 16, 27-40 [CrossRef][Medline] [Order article via Infotrieve]
  14. Bozeman, P. M., Learn, D. B., and Thomas, E. L. (1990) J. Immunol. Methods 126, 125-133 [CrossRef][Medline] [Order article via Infotrieve]
  15. Worthington Enzyme Manual (1972) p. 43, Worthington Biochemical Corp., Freehold, NJ
  16. Summers, M. R., Jacobs, A., Tudway, D., Perera, P., and Ricketts, C. (1979) Br. J. Haematol. 42, 547-555 [Medline] [Order article via Infotrieve]
  17. Finkelstein, E., Rosen, G. M., and Rauckman, E. J. (1980) J. Am. Chem. Soc. 102, 4994-4999
  18. Bynoe, L. A., Pou, S., Gottsch, J. D., and Rosen, G. M. (1991) Biochem. Biophys. Res. Commun. 179, 1305-1310 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.